Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients


BAKKALOĞLU EZGÜ S. A., Kandur Y., Serdaroglu E., Noyan A., KARABAY BAYAZIT A., Tasdemir M., ...Daha Fazla

PEDIATRIC NEPHROLOGY, cilt.33, sa.11, ss.2143-2150, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 11
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s00467-018-4013-4
  • Dergi Adı: PEDIATRIC NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2143-2150
  • Anahtar Kelimeler: Dialysis, Hemoglobin cycling, Left ventricular hypertrophy, Pediatric patients, LEFT-VENTRICULAR HYPERTROPHY, CHRONIC KIDNEY-DISEASE, HEMODIALYSIS-PATIENTS, LEVEL VARIABILITY, BLOOD-PRESSURE, ANEMIA, ERYTHROPOIETIN, MORTALITY, ASSOCIATIONS, CHILDREN
  • Gazi Üniversitesi Adresli: Evet

Özet

During erythropoietin-stimulating agent (ESA) treatment, hemoglobin (Hb) levels usually fluctuate; this phenomenon is known as "Hb cycling (HC)." In this study, we aimed to evaluate the predictors of HC and its impact on left ventricular hypertrophy (LVH) as a patient-important outcome parameter in pediatric dialysis patients.